Heart Failure clinical trials from ESC Congress 2024
With Jozine ter Maaten, University Medical Center Groningen - The Netherlands, Antonio Cannata, King's College London - UK, Mateusz Sokolski, Wroclaw Medical University - Poland, Henrike Arfsten, Medical University of Vienna - Austria, Stefan Anker, Charité University Hospital Berlin - Germany, Muthiuh Vaduganathan, Brigham and Women's hospital, Harvard Medical School Boston - USA, Cornelia Margineanu, Bucharest – Romania and Kengo Kusano, National Cerebral and Cardiovascular Center Hospital, Osaka - Japan.
In this multivoice podcast from the ESC Congress 2024, the main results of three randomized controlled clinical trials (FINEARTS-HF, RESHAPE-HF2, and CRABL-HF) are discussed.
Links to the papers:
FINEARTS-HF
RESHAPE-HF2
This 2024 HFA CardioTalk podcast serie is supported by Novartis in the form of an educational grant. The discussion has not been influenced in any way by its sponsor.
Create your
podcast in
minutes
It is Free